SHORT COMMUNICATION
Nucleotide analogue, method of synthesis of nucleotide
analogue, use of nucleotide analogue, antiviral pro-nucleotide,
pharmaceutical composition
Publication date: 2015-12-21
BioTechnologia 2014;95(4):276-279
ABSTRACT
The object of the invention are 1) nucleotide analogues, 2) antiviral pro-nucleotides, 3) a use of nucleotide analogues and pharmaceutical composition, 4) a phosphorylating agent for synthesis of nucleotide analogue, and 5) a method of synthesis of nucleotide analogues. More precisely, the invention applies to the new group of nucleotide analogues and their use in partial or complete inhibition of human immunodeficiency virus (HIV).
REFERENCES (2)
1.
Romanowska J., Sobkowski M., Szymanska-Michalak A., Kolodziej K., Dąbrowska A., Lipniacki A., Piasek A., Pietrusiewicz Z.M., Figlerowicz M., Guranowski A., Boryski J., Stawinski J., Kraszewski A. (2011) Aryl H- Phosphonates.
2.
17: ( N- Aryl)phosphoramidates of Pyrimidine Nucleoside Analogues and Their Synthesis, Selected Properties, and Anti-HIV Activity. J. Med. Chem. 6482-6491.
| eISSN: | 2353-9461 |
| ISSN: | 0860-7796 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
